U.S. Physical Therapy IncUSPH
Price$85.73Intrinsic value$75.4012% below price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $75.40median of 5 methods · middle span $61-$94based on filings through 31 Dec 2025
Market Price $85.73Price as of 30 Sep 2026
Margin of Safety -12.1%as of 30 Sep 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 8.2% (near-term consensus, capped) · years 2–5: 11.8%/yr (balance of the path).11.0% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 610.0%Yr 78.3%Yr 86.5%Yr 94.8%Yr 103.0%
11.8% → 3.0%
Years 11–20: glide to long-run rate
Per-year rates
Yr 113.0%Yr 123.0%Yr 133.0%Yr 143.0%Yr 153.0%Yr 163.0%Yr 173.0%Yr 183.0%Yr 193.0%Yr 203.0%
3.0% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)-10.5%
Discount rate (cost of equity) 9.9%
Volatility vs market (adjusted beta)1.11

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetU.S. Physical Therapy IncUSPHHealth Care
Valuation
P/E—
P/S1.6×
P/B2.0×
EV / Revenue1.8×
EV / EBITDA12.5×
Profitability
Gross margin19.2%
Operating margin—
Net margin5.1%
FCF margin7.8%
Returns
ROE—
ROA3.3%
ROIC—
Growth
Revenue growth (YoY)16.3%
5-yr fwd EPS growth11.0%
Financial strength
Debt / Equity—
Current ratio—
Altman Z-Score—
Interest coverage—
Dividend yield1.1%

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.